Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients categorised by anatomical site according to the WHO Anatomical Classification of Head and Neck Tumors 5thEd, 2022. Histopathological confirmed cases only Scheduled for definitive Chemoradiotherapy (CRT) with radiation dose 70 Gy.
Exclusion criteria
Exclusion criteria: Systemic Co-morbidities: Cardiovascular diseases (arrhythmias, heart failure), Pulmonary diseases (COPD, asthma), Diabetes Mellitus, Liver disease, or Renal disease or any allergy. Clinical Factors: Concurrent non-HNC malignancies, substance use disorders (drugs), pregnancy, and mentally challenged individuals. Treatment Factors: Patients undergoing primary surgical treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Haematological Predictors wherein these measures evaluate the systemic inflammatory and nutritional status of the patient at critical phases of therapyTimepoint: At Baseline before chemoradiotherapy, During chemoradiotherapy at 3rd week and 3rd month and post chemoradiotherapy at 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Oral Changes wherein these measures assess functional & structural impact on oral cavity by standardised indicesTimepoint: At Baseline before chemoradiotherapy, During chemoradiotherapy at 3rd week and 3rd month and post chemoradiotherapy at 6 month | — |
Countries
India
Contacts
MCODS, Manipal.